Results
2
Companies which are potentially undervalued and in an acceptable financial position.
2 companies
Krka d. d
Market Cap: €6.0b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€189.00
7D
-11.7%
1Y
39.5%
Nova Ljubljanska Banka d.d
Market Cap: €3.5b
Provides various banking services for retail and corporate clients in Slovenia, South East Europe, and Western Europe.
NLBR
€176.00
7D
-1.1%
1Y
46.1%